Tang Capital Management as of June 30, 2013
Portfolio Holdings for Tang Capital Management
Tang Capital Management holds 21 positions in its portfolio as reported in the June 2013 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Pdl Biopharma Inc cnv | 17.2 | $44M | 31M | 1.41 | |
| Mannkind Corp note 3.750%12/1 | 13.3 | $34M | 34M | 0.99 | |
| OPK CB 3 01FEB2033 144A BOND 01feb2033 | 12.1 | $31M | 30M | 1.04 | |
| Pcrx 3 1/4 02/01/19 144a | 10.1 | $26M | 19M | 1.39 | |
| Salix Pharmaceuticals | 7.8 | $20M | 300k | 66.15 | |
| Dendreon Corp note | 7.5 | $19M | 27M | 0.72 | |
| Intermune Inc note 2.500% 9/1 | 5.6 | $14M | 17M | 0.83 | |
| Nektar Therapeutics (NKTR) | 4.1 | $11M | 911k | 11.55 | |
| DepoMed | 4.1 | $10M | 1.8M | 5.62 | |
| BioMarin Pharmaceutical (BMRN) | 4.0 | $10M | 182k | 55.74 | |
| OncoGenex Pharmaceuticals | 3.6 | $9.1M | 933k | 9.80 | |
| MannKind Corporation | 3.0 | $7.7M | 1.2M | 6.50 | |
| Endocyte | 2.4 | $6.1M | 466k | 13.13 | |
| Savient Pharmaceuticals note | 1.8 | $4.6M | 31M | 0.15 | |
| Amarin Corporation Plc note 3.500% 1/1 | 1.1 | $2.7M | 2.5M | 1.09 | |
| Neoprobe | 0.9 | $2.3M | 868k | 2.67 | |
| Rockwell Medical Technologies | 0.6 | $1.6M | 448k | 3.61 | |
| Supernus cv 7.5% | 0.5 | $1.3M | 10M | 0.13 | |
| Dendreon Corporation | 0.1 | $328k | 80k | 4.12 | |
| Cyclacel Pharmaceuticals | 0.1 | $218k | 74k | 2.95 | |
| Ambit Bioscience | 0.0 | $0 | 46.00 | 0.00 |
